Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1175566.RA0leIURvmXqGoRUyvl3nms3ChMtrPzOvs4pywcqU_AE4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1175566.RA0leIURvmXqGoRUyvl3nms3ChMtrPzOvs4pywcqU_AE4130_assertion type Assertion NP1175566.RA0leIURvmXqGoRUyvl3nms3ChMtrPzOvs4pywcqU_AE4130_head.
- NP1175566.RA0leIURvmXqGoRUyvl3nms3ChMtrPzOvs4pywcqU_AE4130_assertion description "[Subcutaneous AT ZAG was reduced in obesity, with a trend to further decrease with prediabetes and type 2 diabetes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1175566.RA0leIURvmXqGoRUyvl3nms3ChMtrPzOvs4pywcqU_AE4130_provenance.
- NP1175566.RA0leIURvmXqGoRUyvl3nms3ChMtrPzOvs4pywcqU_AE4130_assertion evidence source_evidence_literature NP1175566.RA0leIURvmXqGoRUyvl3nms3ChMtrPzOvs4pywcqU_AE4130_provenance.
- NP1175566.RA0leIURvmXqGoRUyvl3nms3ChMtrPzOvs4pywcqU_AE4130_assertion SIO_000772 24753506 NP1175566.RA0leIURvmXqGoRUyvl3nms3ChMtrPzOvs4pywcqU_AE4130_provenance.
- NP1175566.RA0leIURvmXqGoRUyvl3nms3ChMtrPzOvs4pywcqU_AE4130_assertion wasDerivedFrom befree-2016 NP1175566.RA0leIURvmXqGoRUyvl3nms3ChMtrPzOvs4pywcqU_AE4130_provenance.
- NP1175566.RA0leIURvmXqGoRUyvl3nms3ChMtrPzOvs4pywcqU_AE4130_assertion wasGeneratedBy ECO_0000203 NP1175566.RA0leIURvmXqGoRUyvl3nms3ChMtrPzOvs4pywcqU_AE4130_provenance.